Top
The paper's citation list
No.The paper's citation list
1Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. 2018;175:1731 doi: 10.1016/j.cell.2018.10.014
2Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. 2018;59:391 doi: 10.1016/j.intimp.2018.03.002